PHE - Corporate - Antimicrobial Resistance on Common Surgical Procedures
The main goal of this work is to quantify the major so-called- 'secondary effects' of ABR that are predicted to rise as resistance rises in the population.To quantify the indirect cost of ABR on surgical interventions, the project will establish a prioritised list of surgical interventions that would be affected by ABR and how likely the risk of an untreatable infection would have to be for surgery to be avoided for a range of surgical categories.
Buyer
Public Health England
Value
£95,488
Published
13 Jan 2020
Closes
13 Dec 2019
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other Competition From Framework
Category
Services
Contract starts
13 Jan 2020
Contract ends
31 Mar 2020
CPV classifications
75122000
Administrative healthcare services
Lots
Lot default PHE - Corporate - Antimicrobial Resistance on Common Surgical Procedures
£95,488
The main goal of this work is to quantify the major so-called- 'secondary effects' of ABR that are predicted to rise as resistance rises in the population.To quantify the indirect cost of ABR on surgical interventions, the project will establish a prioritised list of surgical interventions that would be affected by ABR and how likely the risk of an untreatab...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
13 Jan 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.